Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?


Creative Commons License

Ordu Ç., Selcuk N. A. , ERDOĞAN E. B. , Angın G., Güral Z., Memiş H., et al.

MEDICINE, cilt.93, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET), in patients with metastatic non-small-cell lung cancer (NSCLC).